A substantial cohort of epithelial ovarian cancers also demonstrated PD-L1 positivity with 9.2% of endometrioid and 7.4% of serous ovarian cancers having >5% PD-L1 expression [45]. The gene discussed is CD274; the disease is ovarian serous adenocarcinoma.